CMCdG, a Novel Nucleoside Analog, Exerts Potent Activity Against Wild-Type and Entecavir-Resistant HBV With Favorable Safety Feature

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02143-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Novel HIV1 Non-Nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines With High Potency Against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus

English

Renal Safety of Tenofovir and/or Entecavir in Patients With Chronic HBV Monoinfection

Therapeutics and Clinical Risk Management
2017English

The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-resistant Melanomas

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

ACHN-490, a Neoglycoside With Potent in Vitro Activity Against Multidrug-Resistant Klebsiella Pneumoniae Isolates

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

A Novel Chimeric Endolysin With Antibacterial Activity Against Methicillin-Resistant Staphylococcus Aureus

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2017English

A Novel Ketolide, RBx 14255, With Activity Against Multidrug-Resistant Streptococcus Pneumoniae

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Clofarabine, a Novel Nucleoside Analog, Is Active in Pediatric Patients With Advanced Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Manadomanzamines a and B: A Novel Alkaloid Ring System With Potent Activity Against Mycobacteria and HIV-1.

ChemInform
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy